Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Go back to Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: INTS) Delayed: 4.11 +0.01 (0.24%)
Previous Close $4.10    52 Week High
Open $4.07    52 Week Low
Day High $4.11    P/E N/A 
Day Low $4.06    EPS
Volume 5,901